(RTTNews) - Aurora Cannabis Inc. (ACB.TO), a medical cannabis company based in Canada, Thursday has announced the discovery of a novel genetic resistance source against powdery mildew, known as PM2.

ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

Aurora said that is has discovered a novel source of genetic resistance against powdery mildew, which it has called PM2, that provides strong protection against the pathogen in cannabis sativa.

Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...

Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science. EDMONTON, AB , March 20, ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of ...